About: Leukocyte-derived interferon (alpha) in human breast carcinoma. The American Cancer Society phase II trial

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Leukocyte-derived interferon (alpha) in human breast carcinoma. The American Cancer Society phase II trial Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 July 1982

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в липні 1982 (uk) im Juli 1982 veröffentlichter wissenschaftlicher Artikel (de) scientific article published on 01 July 1982 (en) artículu científicu espublizáu en xunetu de 1982 (ast)
publication date	wds:Q72669493-59314445-73A7-4D93-90F1-160A5AF3EB04
publication date	1982-07-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q72669493-483F0488-6009-4CCC-A8EA-EEA2E3D1BA55
language of work or name	English
author name string	wds:Q72669493-20D352E0-7B5E-4656-8F33-1509DF79196A wds:Q72669493-2910AF54-3C40-4259-B475-D20BB7479577 wds:Q72669493-4F17C267-D41C-4F87-83F2-FB9102DAE3BC wds:Q72669493-60B842C9-CF40-4ACE-A58C-904E9C08014A wds:Q72669493-7D999EC3-2609-4471-90FA-A137FBB56616 wds:Q72669493-CFF26C40-04D4-4241-85D0-E809D906618B wds:Q72669493-EDC408B8-392B-4CC4-9622-D1AEB2A38856
author name string	J Patel J U Gutterman Y C Chang E C Borden J F Holland T L Dao L Wiener
rdfs:label	Leukocyte-derived interferon (nl) Leukocyte-derived interferon (alpha) in human breast carcinoma. The American Cancer Society phase II trial (en)
skos:prefLabel	Leukocyte-derived interferon (nl) Leukocyte-derived interferon (alpha) in human breast carcinoma. The American Cancer Society phase II trial (en)
name	Leukocyte-derived interferon (nl) Leukocyte-derived interferon (alpha) in human breast carcinoma. The American Cancer Society phase II trial (en)
title	wds:Q72669493-16E0EF1B-4890-46A4-A484-94A2BCF97A5B
title	Leukocyte-derived interferon (alpha) in human breast carcinoma. The American Cancer Society phase II trial (en)
page(s)	wds:Q72669493-795C818F-FEBE-4063-8175-BFFEEA4863A7
page(s)	1-6
instance of	wds:Q72669493-CAF036E2-F541-4A06-A5EF-D6FCC7056C67
instance of	scholarly article
main subject	wds:Q72669493-258F9644-575D-4F83-9502-3E9D4A7CF99B
main subject	phase II clinical trial
PubMed ID	wds:Q72669493-A4241827-CBDB-4DA6-A056-FEFD3E39E724
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/6178335
PubMed ID	6178335
published in	wds:Q72669493-204C7EE2-2AFE-48BF-9EF1-776BE5F076E5
published in	Annals of Internal Medicine
issue	wds:Q72669493-935CA7B4-D2DA-45D0-8CF7-0300D2F9BF09
volume	wds:Q72669493-13C63AA1-2C94-466A-95CA-37EB72BEF847
issue	1
volume	97
DOI	wds:Q72669493-2BB5DA7E-23E8-447A-824F-6E9B004061FE
DOI	http://dx.doi.org/10.7326/0003-4819-97-1-1
DOI	10.7326/0003-4819-97-1-1
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q72669493
is cites work of	Effects of Leukocyte Interferon on Clinical Symptoms and Hormone Levels in Patients with Mid-Gut Carcinoid Tumors and Carcinoid Syndrome Diminished responsiveness of male homosexual chronic hepatitis B virus carriers with HTLV-III antibodies to recombinant alpha-interferon Interferon-gamma and TRAIL in human breast tumor cells Beta interferon regulation of glucose metabolism is PI3K/Akt dependent and important for antiviral activity against coxsackievirus B3. Interferons: current status and future directions of this prototypic biological Biological response modifiers: Preclinical evaluation and clinical activity The immunology and immunotherapy of breast cancer: an update Antitumour actions of interferons: implications for cancer therapy Approaches to cancer therapy using biological response modifiers Human lymphoblastoid interferon. In vitro and in vivo studies in hepatocellular carcinoma Phase II evaluation of interferon added to tamoxifen in the treatment of metastatic breast cancer. The interferons Treatment of advanced renal cell cancer with recombinant interferon alpha as a single agent and in combination with medroxyprogesterone acetate. A randomized multicenter trial Interferon—Present and Future Prospects Low doses of interferon alpha result in more effective clinical natural killer cell activation The role of interferons in the treatment of malignant neoplasms Progress toward therapeutic application of interferons, 1979–1983 Megestrol acetate plus alpha 2a interferon as second line therapy for postmenopausal patients with advanced breast cancer: results of a multicentric phase II trial Alpha-interferon treatment for adult T cell leukemia: low levels of circulating alpha-interferon and it's clinical effectiveness Biological therapy of cancer Inhibition of hormone-dependent and independent breast cancer cell growth in vivo and in vitro with the antiestrogen toremifene and recombinant human interferon-alpha 2 Bone marrow changes in patients with hairy cell leukemia treated by recombinant alpha 2-interferon. Cancer vaccine development: designing tumor cells for greater immunogenicity Recombinant gamma interferon in advanced breast cancer: a phase II trial Treatment of patients with disseminated colorectal cancer with recombinant human alpha2-interferon. Studies on the immune system CD8+ suppressor cells inhibit staphylococcal protein A-induced gamma interferon production by CD4+ lymphocytes Biological response modifiers in the management of patients with breast cancer Evaluation of the natural killer cell-interferon system in patients with mid-gut carcinoid tumours treated with leucocyte interferon Harnessing the immune system in the battle against breast cancer. Clinical and immunological evaluation of 20 patients with advanced colorectal cancer treated with high dose recombinant leukocyte interferon-alpha A (rIFN alpha A). Human recombinant interferon-beta SER and tamoxifen: growth suppressive effects for the human breast carcinoma MCF-7 grown in the athymic mouse Effect of interferon alpha, interferon beta, and interferon gamma on the in vitro growth of human renal adenocarcinoma cells The antitumor effects of interferon. Serum beta 2 microglobulin in adult myeloid acute leukemias Interferons and cancer therapy Combining interferon with cytotoxic chemotherapy in patients with advanced breast cancer The placebo effect. Use outside trials may be unethical Interferon in the treatment of cancer.
is cites work of	wds:Q38164278-351CCD48-7147-4734-8445-419BA907E09C wds:Q40109995-E242270C-B413-4AD5-9C0B-BC387D2A04FA wds:Q38208932-87193F07-6166-4026-97A0-4A7E0465D794 wds:Q72702734-EFA3D7B1-F9BE-4CC7-9D52-91F5A257BA41 wds:Q70049878-29DA3FB3-2329-47E8-8F77-4410F9B6DF7F wds:Q68414562-BA9BC528-CBFB-4D17-94F6-2E8AD8AA5707 wds:Q54291762-878455FD-46D1-42C4-AA26-D387D1D7A695 wds:Q42384053-E8808FA5-B725-4910-A374-B75CFF44449B wds:Q54075479-6E7AC02C-D89D-4B5D-AF7C-7A1236D4D1F5 wds:Q68297310-1ACC677E-C050-40F6-B3DE-44DFA551F1BD wds:Q38015061-29A65414-AC6C-4B6D-864E-F23B38F4545D

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 188 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software